A sensitive method for quantitative measurement of plasma dna: a marker for cancer progression and treatment
Mei Zhang(Anhui Medical University), Lurong Zhang(Fujian Medical University), Kunzhong Zhang(University of Rochester Medicine), Hengshan Zhang(University of Rochester Medicine), Wei Wang(Fujian Normal University), Lulu Zhang(Unknown), Aiguo Zhang(Henan University), Yunqing Ma(Paragon Genomics (United States)), Chaomei Liu(The University of Texas MD Anderson Cancer Center), Shanmin Yang(University of Florida Health), Bruce M. Fenton(University of Rochester Medicine), Liangjie Yin(University of Rochester Medicine), Weimin Sun(Southern Medical University), Peter Keng(University of Rochester Medicine), Paul Okunieff(Unknown)
Cancer Research
May 1, 2008
Cited by 0
Related Papers
The OxyS regulatory RNA represses rpoS translation and binds the Hfq (HF‐I) protein
|The EMBO Journal|1998|788
Tight junction defects in patients with atopic dermatitis
|Journal of Allergy and Clinical Immunology|2010|741
Evaluation of DNA microarray results with quantitative gene expression platforms
|Nature Biotechnology|2006|619
Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol
|International Journal of Radiation Oncology*Biology*Physics|2004|564